- Home
- KYMR vs QTWO Comparison
KYMR vs QTWO Comparison
Compare KYMR & QTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- QTWO
- Stock Information
- Founded
- KYMR 2015
- QTWO 2004
- Country
- KYMR United States
- QTWO United States
- Employees
- KYMR N/A
- QTWO N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- QTWO Computer Software: Prepackaged Software
- Sector
- KYMR Health Care
- QTWO Technology
- Exchange
- KYMR Nasdaq
- QTWO Nasdaq
- Market Cap
- KYMR 4.7B
- QTWO 4.7B
- IPO Year
- KYMR 2020
- QTWO 2014
- Fundamental
- Price
- KYMR $67.94
- QTWO $72.76
- Analyst Decision
- KYMR Strong Buy
- QTWO Buy
- Analyst Count
- KYMR 19
- QTWO 15
- Target Price
- KYMR $69.58
- QTWO $100.93
- AVG Volume (30 Days)
- KYMR 722.7K
- QTWO 1.0M
- Earning Date
- KYMR 11-04-2025
- QTWO 11-05-2025
- Dividend Yield
- KYMR N/A
- QTWO N/A
- EPS Growth
- KYMR N/A
- QTWO N/A
- EPS
- KYMR N/A
- QTWO 0.51
- Revenue
- KYMR $43,735,000.00
- QTWO $769,632,000.00
- Revenue This Year
- KYMR $60.88
- QTWO $15.14
- Revenue Next Year
- KYMR N/A
- QTWO $10.56
- P/E Ratio
- KYMR N/A
- QTWO $143.72
- Revenue Growth
- KYMR N/A
- QTWO 13.93
- 52 Week Low
- KYMR $19.45
- QTWO $58.57
- 52 Week High
- KYMR $68.80
- QTWO $112.82
- Technical
- Relative Strength Index (RSI)
- KYMR 68.81
- QTWO 60.71
- Support Level
- KYMR $63.86
- QTWO $68.39
- Resistance Level
- KYMR $68.80
- QTWO $72.39
- Average True Range (ATR)
- KYMR 3.52
- QTWO 2.27
- MACD
- KYMR 0.19
- QTWO 0.35
- Stochastic Oscillator
- KYMR 94.07
- QTWO 70.99
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About QTWO Q2 Holdings Inc.
Q2 Holdings Inc. is a provider of cloud-based virtual banking solutions for regional financial institutions to deliver mobile banking services to retail and commercial end-users who wish to bank anywhere and anytime. Its solutions operate on an integrated tablet-first platform which provides financial institutions a comprehensive view of account holder activity and meets the regulatory and security requirements applicable to the industry. The firm generates revenue from subscription-based arrangements for software offerings. A large majority of the firm's revenue is generated in the United States.